Company Overview and News

 
Japanese companies see big things in small-scale industrial robots - Channel NewsAsia

2018-04-20 channelnewsasia
A two-armed robot in a Japanese factory carefully stacks rice balls in a box, which a worker carries off for shipment to convenience stores. At another food-packaging plant, a robot shakes pepper and powdered cheese over pasta that a person has just arranged in a container.
Upvote Downvote

 
Japanese companies see big things in small-scale industrial robots

2018-04-20 reuters
TOKYO, April 20 (Reuters) - A two-armed robot in a Japanese factory carefully stacks rice balls in a box, which a worker carries off for shipment to convenience stores. At another food-packaging plant, a robot shakes pepper and powdered cheese over pasta that a person has just arranged in a container.
Upvote Downvote

 
Nikkei meanders downward as concerns over Syria loom

2018-04-12 japantimes.co.jp
Stocks closed slightly lower in directionless trading Thursday, with active traders held in check partly by growing concerns over Syria.
Upvote Downvote

1
Tokyo stocks rebound on futures-led buying and weak yen

2018-04-09 japantimes.co.jp
Stocks rebounded on the Tokyo Stock Exchange on Monday, buoyed by futures-led buying and the yen’s weakening against the dollar.
Upvote Downvote

 
Nikkei falls, hit by tech stocks; Monex jumps on possible Coincheck purchase

2018-04-03 reuters
TOKYO, April 3 (Reuters) - Japanese stocks fell on Tuesday, led by tech firms and makers of electronic components after U.S. tech stocks tumbled overnight on resurgent trade war fears, while Monex jumped after saying it might buy cryptocurrency exchange Coincheck.
Upvote Downvote

 
Nikkei falls as tech, electronic component stocks underperform

2018-04-03 thehindubusinessline
Nintendo Co stumbled 2.8 per cent, Nikon Corp dropped 2.1 per cent and Fanuc Corp stumbled 2.8 per cent.
Upvote Downvote

 
Nikkei falls as tech, electronic components stocks underperform

2018-04-03 reuters
TOKYO, April 3 (Reuters) - Japan’s Nikkei share average fell on Tuesday morning, led by technology firms and makers of electronic components after U.S. tech stocks tumbled overnight on resurgent trade war fears.
Upvote Downvote

 
As China climbs the value chain, a new trade challenge looms in Asia

2018-03-26 japantimes.co.jp
China’s rampant economic growth has been a boon for exporters in Japan, South Korea and Taiwan, who have supplied high-end components and machines for its factories. The risk for them now is that China will switch from customer to competitor as it ascends the value chain.
Upvote Downvote

 
China's Push for Tech Self-Sufficiency Threatens Asia's Exporters - Bloomberg

2018-03-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
As Trump takes on China, another trade challenge looms in Asia

2018-03-25 themalaymailonline
With China pouring in billions into homegrown semiconductor manufacturing, there’s potential for trade flows to start to shift. — Reuters picHONG KONG, March 26 — China’s rampant economic growth has been a boon for exporters in Japan, South Korea and Taiwan, who’ve supplied high-end components and machines for its factories. The risk for them now is that China changes from customer to competitor as it ascends the value chain.
Upvote Downvote

 
Nikkei closes down nearly 1,000 points on trade war jitters

2018-03-23 japantimes.co.jp
Stocks nose-dived on the Tokyo Stock Exchange Friday due to intensifying concerns over a trade war between the United States and China, with the benchmark 225-issue Nikkei average finishing with a loss of nearly 1,000 points.
Upvote Downvote

 
Nikkei falls as tech shares weak; investors cautious before holiday and Fed

2018-03-20 reuters
TOKYO, March 20 (Reuters) - Japan’s Nikkei share average fell on Tuesday as domestic tech stocks tracked U.S. counterparts’ declines on Wall Street, but declines were limited as investors refrained from taking large positions before the Federal Reserve meeting.
Upvote Downvote

 
Nikkei falls as U.S. tech share weakness hurts risk appetite

2018-03-20 reuters
TOKYO, March 20 (Reuters) - Japan’s Nikkei share average fell on Tuesday morning as local tech stocks tracked their U.S. counterparts’ declines on Wall Street, which knocked other sectors into negative territory.
Upvote Downvote

 
Tokyo stocks advance further on halt to yen’s rise

2018-03-13 japantimes.co.jp
Stocks gained further ground Tuesday on the Tokyo Stock Exchange thanks to a halt of the yen’s strengthening against the dollar.
Upvote Downvote

 
Patiently Waiting For Investment Opportunities In Rapidly Growing Industries

2018-03-12 seekingalpha
Many great companies are expensive in the current economic boom. Nevertheless, now it's the right time to analyze potential candidates for future investments.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...